Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury

Background—Growth factors play an essential role in organogenesis. We examine the potential of growth factors to enhance cell engraftment and differentiation and to promote functional improvement after transfer of undifferentiated embryonic stem cells into the injured heart. Methods and Results—Green fluorescent protein (GFP)–positive embryonic stem cells derived from 129sv mice were injected into the ischemic area after left anterior descending artery ligation in allogenic (BALB/c) mice. Fifty nanograms of recombinant mouse vascular endothelial growth factor, fibroblast growth factor (FGF), and transforming growth factor (TGF) was added to the cell suspension. Separate control groups were formed in which only the growth factors were given. Echocardiography was performed 2 weeks later to evaluate heart function (fractional shortening [FS]), end-diastolic diameter, and left ventricular wall thickness). Hearts were harvested for histology (connexin 43, α-sarcomeric actin, CD3, CD11c, major histocompatability complex class I, hematoxylin-eosin). Degree of restoration (GFP-positive graft/infarct area ratio), expression of cardiac markers, host response, and tumorigenicity were evaluated. Cell transfer resulted in improved cardiac function. TGF-β led to better restorative effect and a stronger expression of connexin 43, α-sarcomeric actin, and major histocompatability complex class I. TGF-β and FGF retained left ventricular diameter. FS was better in the TGF-β, FGF, and embryonic stem cells–only group compared with left anterior descending artery–ligated controls. Growth factors with cells (TGF-β, FGF) resulted in higher FS and smaller end-diastolic diameter than growth factors alone. Conclusions—Growth factors can promote in vivo organ-specific differentiation of early embryonic stem cells and improve myocardial function after cell transfer into an area of ischemic lesion. TGF-β should be considered as an adjuvant for myocardial restoration with the use of embryonic stem cells.

[1]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[2]  J. Hartikainen,et al.  Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart , 2004, Circulation.

[3]  P. Menasché.  Skeletal myoblast transplantation for cardiac repair , 2004, Expert review of cardiovascular therapy.

[4]  S. Ylä-Herttuala,et al.  Evolving revascularization approaches for myocardial ischemia. , 2003, The American journal of cardiology.

[5]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Doevendans,et al.  Transplantation of cells for cardiac repair. , 2003, Journal of the American College of Cardiology.

[7]  M. Pampusch,et al.  Effect of recombinant porcine IGF-binding protein-3 on proliferation of embryonic porcine myogenic cell cultures in the presence and absence of IGF-I. , 2003, The Journal of endocrinology.

[8]  A. Terzic,et al.  Stem cell differentiation requires a paracrine pathway in the heart , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[10]  Yong-Fu Xiao,et al.  VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. , 2002, Journal of applied physiology.

[11]  Karl A. Tomlinson,et al.  Cardiac Microstructure: Implications for Electrical Propagation and Defibrillation in the Heart , 2002, Circulation research.

[12]  H. Rubin.  The disparity between human cell senescence in vitro and lifelong replication in vivo , 2002, Nature Biotechnology.

[13]  F. Gámiz,et al.  Electron transport in strained Si inversion layers grown on SiGe-on-insulator substrates , 2002 .

[14]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[15]  P. Doevendans,et al.  Cardiomyocyte differentiation of mouse and human embryonic stem cells * , 2002, Journal of anatomy.

[16]  P. Anversa,et al.  Myocyte growth and cardiac repair. , 2002, Journal of molecular and cellular cardiology.

[17]  E. Matunis,et al.  Control of Stem Cell Self-Renewal in Drosophila Spermatogenesis by JAK-STAT Signaling , 2001, Science.

[18]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[19]  M. Yacoub,et al.  Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. , 2001, The Annals of thoracic surgery.

[20]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[21]  J M Guccione,et al.  Mechanism underlying mechanical dysfunction in the border zone of left ventricular aneurysm: a finite element model study. , 2001, The Annals of thoracic surgery.

[22]  J. Prados,et al.  Development of Chick Cardiomyocytes: Modulation of Intermediate Filaments by Basic Fibroblast and Platelet-Derived Growth Factors , 2000, Cells Tissues Organs.

[23]  R. Weisel,et al.  Autologous heart cell transplantation improves cardiac function after myocardial injury. , 1999, The Annals of thoracic surgery.

[24]  Andrew D McCulloch,et al.  Laminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium. , 1999, American journal of physiology. Heart and circulatory physiology.

[25]  Lei Wang,et al.  Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. , 1998, Circulation research.

[26]  B. Fleischmann,et al.  Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. , 1997, Cardiovascular research.

[27]  J. Isner,et al.  Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. , 1997, The Annals of thoracic surgery.

[28]  P. Hunter,et al.  Laminar structure of the heart: a mathematical model. , 1997, The American journal of physiology.

[29]  D. Kolansky,et al.  Gene therapy for ischemic heart disease. , 1996, Current opinion in cardiology.

[30]  F. Ruscetti,et al.  Transforming growth factor-beta1 in heart development , 1992, Mechanisms of Development.

[31]  B. Doble,et al.  Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. , 1991, The Journal of biological chemistry.

[32]  F. Sogorb,et al.  Growth hormone therapy, is it always good for the heart? , 2004, European heart journal.

[33]  J. Morgan,et al.  Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. , 2002, Journal of applied physiology.

[34]  Y. Jan,et al.  Control of cell divisions in the nervous system: symmetry and asymmetry. , 2000, Annual review of neuroscience.

[35]  H. Lin,et al.  Neuroblasts: a model for the asymmetric division of stem cells. , 1997, Trends in genetics : TIG.

[36]  F. Ruscetti,et al.  Transforming growth factor-beta 1 in heart development. , 1992, Mechanisms of development.